Financial toxicity, time toxicity, and quality of life in multiple myeloma

Patients with multiple myeloma (MM) may be on therapy for years, which can lead to financial toxicity (FinTox) or time toxicity (TimeTox). The prevalence, predictors, and quality of life (QOL) impacts of FinTox and TimeTox during different phases of MM treatment have not been characterized.

Source: Clinical Lymphoma, Myeloma and Leukemia - February 22, 2024 Category: Hematology Authors: Rahul Banerjee, Andrew J. Cowan, Marivel Ortega, Constance Missimer, Paul A. Carpenter, Masumi Ueda Oshima, Rachel B. Salit, Phuong T. Vo, Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher T. Su Source Type: research